维拉帕米对精神分裂症患者迟发性运动障碍和精神病的影响。
Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients.
作者信息
Reiter S, Adler L, Angrist B, Peselow E, Rotrosen J
机构信息
Psychiatry Service, New York Veterans Administration Medical Center, NY 10010.
出版信息
J Clin Psychiatry. 1989 Jan;50(1):26-7.
PMID:2562952
Abstract
Nine hospitalized schizophrenic patients with tardive dyskinesia were treated with the calcium-channel antagonist verapamil under single-blind conditions. The tardive dyskinesia and activation scores decreased, and the anxiety/depression scores increased. The changes were small but statistically significant.
摘要
九名患有迟发性运动障碍的住院精神分裂症患者在单盲条件下接受了钙通道拮抗剂维拉帕米的治疗。迟发性运动障碍和激活性评分降低，焦虑/抑郁评分升高。这些变化虽小，但具有统计学意义。
Zotero 插件